Simvastatin News
Simvastatin currently has 1 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Simvastatin with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Cholib is indicated as adjunctive therapy to diet and exercise in high cardiovascular risk adult patients with mixed dyslipidaemia to reduce triglycerides and increase HDL C levels when LDL C levels...
- Evidence level: L1
- Predicted indications (20):
- homozygous familial hypercholesterolemia (100.0%)
- obsolete familial combined hyperlipidemia (99.9%)
- hyperlipidemia, familial combined, LPL related (99.9%)
- hyperlipoproteinemia (99.8%)
- obsolete susceptibility to ischemic stroke (99.7%)
- familial hypercholesterolemia (99.6%)
- brain stem infarction (99.4%)
- cholesterol-ester transfer protein deficiency (99.4%)
- hypercholesterolemia, autosomal dominant (99.4%)
- hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency (99.3%)
- HIV infectious disease (99.2%)
- cerebral infarction (99.2%)
- hypoalphalipoproteinemia (99.1%)
- ABri amyloidosis (99.1%)
- neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter (99.1%)
- fibroma of prostate (98.9%)
- feline acquired immunodeficiency syndrome (98.8%)
- simian immunodeficiency virus infection (98.8%)
- cerebral artery occlusion (98.7%)
- benign reproductive system neoplasm (98.7%)
Related News (1)
Rivoluzione incretine, i farmaci anti-obesità ora diventano pillole. «Dosaggi saranno più facili da gestire» - Il Messaggero
2026-10-10 tumor ictus obesità
Source: Il Messaggero
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.